Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;140(1):95-97.
doi: 10.1007/s00401-020-02149-3. Epub 2020 Mar 17.

Genome-wide DNA methylation profiles distinguish silent from non-silent ACTH adenomas

Affiliations

Genome-wide DNA methylation profiles distinguish silent from non-silent ACTH adenomas

Franz L Ricklefs et al. Acta Neuropathol. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig.1
Fig.1
Genome-wide DNA methylation profiles split ACTH adenomas into clinically relevant subgroups. a Corticotroph adenomas causing either Cushing’s disease (CD) or being clinically silent (SCA) show strong expression of adrenocorticotrophic hormone (ACTH). Scale bar: 100 µm. b SCA patients have larger tumors in comparison to CD as measured by MRI (p < 0.0001). c Cumulative copy number alterations (CNA) inferred from the DNA methylation data. Healthy pituitary gland samples derived from the publicly accessible Capper set [2] were used as controls. d Heat map using pairwise Pearson correlation coefficients of the 10,000 most variable CpG features across all 36 samples reveals two distinct CD and SCA clusters and a third group with a clinically heterogeneous picture. No AL = no anterior lobe. eT-Distributed Stochastic Neighbor Embedding (t-SNE) of all methylation probes indicates that SCA and CDs are distinguishable by their epigenetic profiles. fT-SNE analysis with all 36 ACTH adenomas merged with the CNS tumor reference cohort from Capper et al. (2018).

References

    1. Ben-Shlomo A, Cooper O. Silent corticotroph adenomas. Pituitary. 2018;21:183–193. doi: 10.1007/s11102-018-0864-8. - DOI - PubMed
    1. Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555:469–474. doi: 10.1038/nature26000. - DOI - PMC - PubMed
    1. Capper D, Stichel D, Sahm F, Jones DTW, Schrimpf D, Sill M, et al. Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience. Acta Neuropathol. 2018;136:181–210. doi: 10.1007/s00401-018-1879-y. - DOI - PMC - PubMed
    1. Dimopoulou C, Schopohl J, Rachinger W, Buchfelder M, Honegger J, Reincke M, et al. Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing’s disease: care reality in the Munich Metropolitan Region. Eur J Endocrinol. 2014;170:283–292. doi: 10.1530/EJE-13-0634. - DOI - PubMed
    1. Lloyd R, Osamura R, Klöppel G, Rosai J. WHO Classification of Tumours. 4. Loyon: International Agency for Research on Cancer; 2017. WHO Classification of Tumours of Endocrine Organs.

Publication types

MeSH terms

LinkOut - more resources